Addressing antimicrobial resistance with digital approaches

In 2021, bacterial antimicrobial resistance (AMR) was linked to 4.71 million deaths, with 1.14 million directly attributable to it. By 2050, AMR could cause 1.91 million direct deaths and 8.22 million associated deaths globally. Digital technologies have the potential to play a crucial role in combating this pressing global health issue. This Series in The Lancet Digital Health features three papers discussing the latest advancements and challenges in digital health approaches to AMR. The papers explore

Read the full article here

Source: www.thelancet.com

Categories: Future of Medicine, General Medicine News

Tweets with this article

The Lancet Digital Health

By 2050, antimicrobial resistance (AMR) could cause 1.91 million direct deaths and 8.22 million associated deaths globally. A new @LancetDigitalH Series including three papers highlights the potential of digital approaches to reduce the burden of AMR: https://t.co/8tUSGuSiIO https://t.co/GqF4Tnbt35

Glofitamab plus gemcitabine and oxaliplatin (GemOx) versus rituximab-GemOx for relapsed or refractory diffuse large B-cell lymphoma (STARGLO): a global phase 3, randomised, open-label trial

Glofit-GemOx had a significant overall survival benefit compared with R-GemOx, supporting its use in transplant-ineligible patients with relapsed or refractory diffuse large B-cell lymphoma after…

Raul Cordoba, MD, PhD November 15, 2024

Meet Evo, the DNA-trained AI that creates genomes from scratch

ChatGPT-like model learns on its own to devise new proteins and genetic sequences

News from Science November 15, 2024

Bone health in adults with obesity before and after interventions to promote weight loss

Obesity and its associated comorbidities constitute a serious and growing public health burden. Fractures affect a substantial proportion of people with obesity and result from…

The Lancet Diabetes & Endocrinology November 15, 2024

A just world on a safe planet: a Lancet Planetary Health–Earth Commission report on Earth-system boundaries, translations, and transformations

The health of the planet and its people are at risk. The deterioration of the global commons—ie, the natural systems that support life on Earth—is…

The Lancet November 15, 2024

Gene Therapy for Muscular Dystrophy Could Use StitchR to Assemble XL Gene from S Segments

StitchR makes it possible to deliver larger payloads with current vectors, expanding the list of diseases targetable by gene therapies.

Genetic Engineering & Biotechnology News November 15, 2024

Trump, health, science, and the next 4 years

Donald Trump’s decisive re-election as US President on Nov 5 puts many aspects of health and science in a deeply concerning position. Although there is…

The Lancet November 15, 2024

CAR T-Cells Use SNIPR Technology to Confirm Cancer Targets before Firing

Engineered receptors could lead to more precisely targeted, effective cancer therapies with fewer side effects than existing treatments.

Genetic Engineering & Biotechnology News November 15, 2024

Hypothalamic obesity: from basic mechanisms to clinical perspectives

Despite the diverse nature of obesity, there is compelling genetic, clinical, and experimental evidence that endorses the important contribution of brain circuits to this condition.…

The Lancet Diabetes & Endocrinology November 15, 2024

Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S)

SummaryDrug therapy for hypercholesterolaemia has remained controversial mainly because of insufficient clinical trial evidence for improved survival. The present trial was designed to evaluate the…

Raul Santos November 15, 2024

Combining Base and Prime Editing to Decipher Which Gene Variants Lead to Cancer

Researchers at ETH Zurich combined two CRISPR-Cas methods to decipher how mutations in a cell’s genome affect its function. Their new approach can help determine…

Genetic Engineering & Biotechnology News November 15, 2024

Related Articles